Alcami
Alcami is a global contract development and manufacturing organization (CDMO) headquartered in North Carolina, U.S., with over 45 years of experience advancing pharmaceuticals and biologics from development to delivery.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Alcami is a global contract development and manufacturing organization (CDMO) headquartered in North Carolina, U.S. with over 45 years of experience. It provides fully integrated lab services, drug product manufacturing, primary and secondary packaging and labeling, and cGMP pharma storage and support services. Alcami serves pharmaceutical and biotech companies of all sizes, leveraging 1,000,000 ft² across the United States and Europe, with more than 1,000 employees and eight campuses. Its private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners.
History
Alcami is a global contract development and manufacturing organization headquartered in North Carolina, U.S. with over 45 years of experience. It provides fully integrated lab services, drug product manufacturing, primary and secondary packaging and labeling, and cGMP pharma storage and support services. Alcami's private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners. In May 2026, Alcami completed the acquisition of Tjoapack.
Acquisition of Tjoapack
[1]
Recent events
Alcami appoints Walter J. Kaczmarek III as CEO[5]
Reported:
Alcami announced the appointment of Walter J. Kaczmarek III as its chief executive officer.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/alcami · Editorial policy · How profiles are compiled